InsidersTradesSigma
Follow the 宣泰医药 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 宣泰医药 has logged 2 insider filings. Market capitalisation: €4bn. The latest transaction was filed on 23 March 2026 (Purchase). Among the most active insiders: 李方立. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€6,706
2 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,726 of 29,063 companies
47.7
score / 100
Value29
Quality66
FCF yld1.3%
Earn yld1.1%
EV/EBITDA49.4x
ROE3.3%
Gross mgn39%
Net mgn11%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 March 2026
Acerca de 宣泰医药
Xuantai Pharmaceutical es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la Bolsa de Shanghái. Se especializa en el desarrollo y comercialización de productos farmacéuticos.